These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1056 related items for PubMed ID: 10810403

  • 1. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S, Sasano H.
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [Abstract] [Full Text] [Related]

  • 2. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Sasano H.
    Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.
    Suzuki T, Moriya T, Ariga N, Kaneko C, Kanazawa M, Sasano H.
    Br J Cancer; 2000 Feb; 82(3):518-23. PubMed ID: 10682658
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
    Antuofermo E, Miller MA, Pirino S, Xie J, Badve S, Mohammed SI.
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer.
    Oduwole OO, Li Y, Isomaa VV, Mäntyniemi A, Pulkka AE, Soini Y, Vihko PT.
    Cancer Res; 2004 Oct 15; 64(20):7604-9. PubMed ID: 15492288
    [Abstract] [Full Text] [Related]

  • 8. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C, Orosz Z, Kahán Z, Gábor G, Jani N, Cserni G, Hadijev J, Kulka J, Sulyok Z, Boross G, Lázár G, László Z, Diczházi C, Udvarhelyi N, Szabó E, Péntek Z, Major T, Fodor J.
    Magy Onkol; 2008 Sep 15; 52(3):269-77. PubMed ID: 18845497
    [Abstract] [Full Text] [Related]

  • 9. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
    Utsunomiya H, Suzuki T, Kaneko C, Takeyama J, Nakamura J, Kimura K, Yoshihama M, Harada N, Ito K, Konno R, Sato S, Okamura K, Sasano H.
    J Clin Endocrinol Metab; 2001 Jul 15; 86(7):3436-43. PubMed ID: 11443221
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.
    Zafrani B, Leroyer A, Fourquet A, Laurent M, Trophilme D, Validire P, Sastre-Garau X.
    Semin Diagn Pathol; 1994 Aug 15; 11(3):208-14. PubMed ID: 7831532
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ.
    Anticancer Res; 1999 Aug 15; 19(3A):2133-9. PubMed ID: 10470161
    [Abstract] [Full Text] [Related]

  • 14. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
    Park SS, Kim JE, Kim YA, Kim YC, Kim SW.
    Histopathology; 2005 Dec 15; 47(6):625-30. PubMed ID: 16324201
    [Abstract] [Full Text] [Related]

  • 15. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, Uyar M.
    Saudi Med J; 2005 Dec 15; 26(12):1889-96. PubMed ID: 16380768
    [Abstract] [Full Text] [Related]

  • 16. New development in intracrinology of breast carcinoma.
    Sasano H, Suzuki T, Nakata T, Moriya T.
    Breast Cancer; 2006 Dec 15; 13(2):129-36. PubMed ID: 16755106
    [Abstract] [Full Text] [Related]

  • 17. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.
    Am J Surg Pathol; 2008 Apr 15; 32(4):544-52. PubMed ID: 18300793
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
    Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S, Kinouchi Y, Kameyama K, Takami H, Shimosegawa T, Sasano H.
    Mod Pathol; 2003 May 15; 16(5):437-44. PubMed ID: 12748250
    [Abstract] [Full Text] [Related]

  • 19. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug 15; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 20. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP, Prioleau JE, Harris JR, Schnitt SJ.
    Cancer; 1996 Feb 01; 77(3):499-506. PubMed ID: 8630957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.